Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.
about
The Antibody Response against HIV-1Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionPassive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization BreadthThe breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants.Disease Progression in HIV-1-Infected Viremic Controllers.
P2860
Q27000889-CEDC7BC8-65B7-4659-92A7-A38E50599B23Q27332360-7E0890E2-7920-4CAF-9D62-FBC4259027EFQ34230556-6B220AA7-46E8-4803-8D41-18F18C0C57EFQ35160124-E4132884-C795-405D-90D7-C2EE14F70238Q35715634-9A9A08EB-DDB6-47FE-B82E-4F8F454E9500Q36171962-4E1F8A14-78DA-41A5-95BB-0FA54B3D202AQ36194234-B57FB057-38F2-4C60-9158-87D755493DE5Q36276632-438CB2F1-0B97-463F-A33F-2A4A379D3C59Q36438523-3009EC11-1704-4110-BCAE-4E2D5FD5FC98Q36559665-58598374-320C-44B5-943A-A8ED9FC0B870Q36810796-06C8CF7A-A325-4580-B536-28E1C2568D49Q37077305-AF035EB1-D32A-41A2-8A09-6821EDCCD1F9
P2860
Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neutralization activity in a g ...... sponse than clade B infection.
@ast
Neutralization activity in a g ...... sponse than clade B infection.
@en
type
label
Neutralization activity in a g ...... sponse than clade B infection.
@ast
Neutralization activity in a g ...... sponse than clade B infection.
@en
prefLabel
Neutralization activity in a g ...... sponse than clade B infection.
@ast
Neutralization activity in a g ...... sponse than clade B infection.
@en
P2093
P50
P356
P1476
Neutralization activity in a g ...... sponse than clade B infection.
@en
P2093
Aine McKnight
Are Isaksen
Carl D'Souza
Corinna Pade
Eithne O'Sullivan
Hanna Dreja
Hongmei Gao
James Hand
Keith Aubin
Kelli M Greene
P304
P356
10.1099/VIR.0.024224-0
P407
P577
2010-08-04T00:00:00Z